MICHELETTO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.028
EU - Europa 140
AS - Asia 137
SA - Sud America 5
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.313
Nazione #
US - Stati Uniti d'America 1.026
CN - Cina 74
VN - Vietnam 40
IE - Irlanda 34
FI - Finlandia 26
DE - Germania 24
IT - Italia 24
GB - Regno Unito 10
CH - Svizzera 7
IN - India 7
IR - Iran 5
KR - Corea 5
SE - Svezia 5
UA - Ucraina 4
CO - Colombia 3
CA - Canada 2
EC - Ecuador 2
NL - Olanda 2
NZ - Nuova Zelanda 2
SG - Singapore 2
SI - Slovenia 2
BD - Bangladesh 1
EU - Europa 1
IL - Israele 1
NO - Norvegia 1
RU - Federazione Russa 1
TR - Turchia 1
TW - Taiwan 1
Totale 1.313
Città #
Woodbridge 158
Fairfield 124
Ann Arbor 121
Chandler 116
Houston 90
Ashburn 53
Wilmington 48
Cambridge 40
Dong Ket 40
Seattle 40
Dublin 33
Guangzhou 23
Des Moines 21
Princeton 21
Jacksonville 18
Roxbury 17
San Diego 17
Medford 15
Nanjing 15
Boardman 10
Helsinki 9
Bristol 6
Cagliari 6
Shenyang 6
Padova 5
Pohang 5
Beijing 4
Changsha 4
Nanchang 4
Jiaxing 3
Shanghai 3
Amsterdam 2
Augsburg 2
Bologna 2
Hebei 2
Milan 2
Taizhou 2
Tianjin 2
Toronto 2
Athens 1
Atlanta 1
Bengaluru 1
Dallas 1
Dhaka 1
Frankfurt Am Main 1
Frankfurt am Main 1
Gunzenhausen 1
Ilmenau 1
Islington 1
Jinan 1
Kashan 1
Kharkiv 1
Kish 1
Los Angeles 1
Murfreesboro 1
New York 1
Ogden 1
Oria 1
Oslo 1
Phoenix 1
Quito 1
Rome 1
Saint Louis 1
Salerno 1
San Jose 1
Sangolqui 1
Singapore 1
Sligo 1
Stockholm 1
Taipei 1
Torino 1
Wellington 1
Wuhan 1
Yenibosna 1
Zhengzhou 1
Totale 1.127
Nome #
In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes 131
The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose. 112
A model of GLP-1 action on insulin secretion in nondiabetic subjects. 108
Model-Based Quantification of Glucagon-Like Peptide-1-Induced Potentiation of Insulin Secretion in Response to a Mixed Meal Challenge 91
Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1. 90
Contribution of Endogenous Glucagon-Like Peptide 1 to Glucose Metabolism After Roux-en-Y Gastric Bypass 82
The UVA/PADOVA Type 1 Diabetes Simulator: New Features. 80
A model of beta-cell response to GLP-1 to quantify incretin effect in healthy and prediabetic subjects 79
A Model of GLP-1 Action on Insulin Secretion in Nondiabetic Subjects 73
Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study. 72
The Updated UVA/Padova Type 1 Diabetes Simulator 67
A Counter-Regulation Model in Type 1 Diabetes 61
A Model of GLP-1 Action on Insulin Secretion during an Oral Test 58
Six and 12 Weeks of Caloric Restriction Increases beta Cell Function and Lowers Fasting and Postprandial Glucose Concentrations in People with Type 2 Diabetes 52
PREDIABETES AND TYPE 2 DIABETES SIMULATOR: IN SILICO TESTING OF NEW DRUGS. DIABETES TECHNOLOGY & THERAPEUTICS 51
Modeling The Effect Of Pramlintide On Meal Glucose Rate Of Appearance In Health. Advanced Technologies & Treatments for Diabetes 49
In Silico Modeling for Clinical Trial Optimization 39
In Silico Determination of a Pramlintide-Insulin Ratio for Co-Administration in Type 1 Diabetes (T1D) 23
Totale 1.318
Categoria #
all - tutte 3.647
article - articoli 2.546
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201986 0 0 0 0 0 0 0 0 0 22 27 37
2019/2020180 36 3 1 13 21 14 18 18 17 11 21 7
2020/2021180 5 9 0 9 4 32 6 20 22 11 12 50
2021/2022219 5 33 22 20 3 7 9 24 3 5 14 74
2022/2023251 45 28 20 15 47 44 3 12 24 0 9 4
2023/2024104 8 13 23 11 1 0 7 19 2 20 0 0
Totale 1.318